32205-72-4

Usage

Uses

Used in the Food and Beverage Industry:
5-Methoxypyrazine-2-carbaldehyde is used as a flavoring agent for its distinctive and pleasant scent, enhancing the taste and aroma of various foods and beverages such as coffee, chocolate, and beer.
Used in the Fragrance and Perfume Industry:
5-Methoxypyrazine-2-carbaldehyde is used as a key ingredient in the production of fragrances and perfumes, adding a unique and appealing scent to these products.
Used in the Pharmaceutical Industry:
5-Methoxypyrazine-2-carbaldehyde serves as a precursor in the synthesis of various pharmaceuticals and organic compounds, contributing to the development of new medications and chemical products.

Upstream product

• 33332-25-1 methyl 5-chloropyrazine-2-carboxylate 
• 38789-75-2 methyl 5-methoxypyrazine-2-carboxylate 
• 72788-88-6 (5-methoxypyrazin-2-yl)methanol 
• 40155-42-8 5-methoxy-pyrazine-2-carboxylic acid 

Relevant academic research and scientific papers

PYRAZOLOPYRIDINE COMPOUND AS RET INHIBITOR AND APPLICATION THEREOF

Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibitors for treatment. Specifically disclosed is the compound represented by formula (I), or a pharmaceutically acceptable salt thereof.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

HETEROARYL SUBSTITUTED HETEROCYCLYL SULFONES

The invention relates to aryl substituted heterocyclyl sulfones as voltage gated calcium channel blockers, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.